558 results on '"UENO, TOSHIHIDE"'
Search Results
2. Cancer risk assessment of premalignant breast tissues from patients with BRCA mutations by genome profiling
3. A molecular glue RBM39-degrader induces synthetic lethality in cancer cells with homologous recombination repair deficiency
4. Maintenance of R-loop structures by phosphorylated hTERT preserves genome integrity
5. Subclonal accumulation of immune escape mechanisms in microsatellite instability-high colorectal cancers.
6. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma
7. Correction: GLI1 confers resistance to PARP inhibitors by activating the DNA damage repair pathway
8. Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia
9. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases
10. Somatic mutations can induce a noninflamed tumour microenvironment via their original gene functions, despite deriving neoantigens
11. Strategic Approach to Heterogeneity Analysis of Cutaneous Adnexal Carcinomas Using Computational Pathology and Genomics
12. Genome Doubling Shapes High-Grade Transformation and Novel EWSR1::LARP4 Fusion Shows SOX10 Immunostaining in Hyalinizing Clear Cell Carcinoma of Salivary Gland
13. HLA Class I Analysis Provides Insight Into the Genetic and Epigenetic Background of Immune Evasion in Colorectal Cancer With High Microsatellite Instability
14. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments
15. PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes
16. Identification of novel prognostic and predictive biomarkers in salivary duct carcinoma via comprehensive molecular profiling
17. Allelic loss of HLA class I facilitates evasion from immune surveillance in cervical intraepithelial neoplasia
18. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities
19. Comprehensive molecular and clinicopathological profiling of desmoid tumours
20. Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels
21. Lymphangioleiomyomatosis as a potent lung cancer risk factor: Insights from a Japanese large cohort study.
22. An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells
23. Identification of Novel CD74-NRG2α Fusion From Comprehensive Profiling of Lung Adenocarcinoma in Japanese Never or Light Smokers
24. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
25. MicroSEC filters sequence errors for formalin-fixed and paraffin-embedded samples
26. Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancer
27. Comprehensive molecular profiling of pulmonary pleomorphic carcinoma
28. Transcript-targeted analysis reveals isoform alterations and double-hop fusions in breast cancer
29. Rapid Response to Lenvatinib and Disease Flare Following Discontinuation in a Patient with Thymic Carcinoma Harboring KIT exon 11 Mutation: A Case Report
30. Integrated molecular profiling of juvenile myelomonocytic leukemia
31. Identification of a Novel MAN1A1-ROS1 Fusion Gene Through mRNA-based Screening for Tyrosine Kinase Gene Aberrations in a Patient with Leiomyosarcoma
32. A germline HLTF mutation in familial MDS induces DNA damage accumulation through impaired PCNA polyubiquitination
33. Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
34. High-throughput functional evaluation of BRCA2 variants of unknown significance
35. KRAS mutations in uterine endometrium are associated with gravidity and parity
36. Supplementary Table S4 from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
37. Supplementary Figure S2 from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
38. Supplementary Table S3A-B from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
39. Data from Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
40. Clinical Activity and Exploratory Resistance Mechanism of Milademetan, an MDM2 Inhibitor, in Intimal Sarcoma with MDM2 Amplification: An Open-Label Phase Ib/II Study
41. Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations
42. Supplementary Figure S6 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
43. Supplementary Table S8 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
44. Data from Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia
45. Supplementary Data from Targeting MEF2D-fusion Oncogenic Transcriptional Circuitries in B-cell Precursor Acute Lymphoblastic Leukemia
46. Data from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration
47. Supplementary Tables from High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer
48. Data from High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer
49. Supplementary Figure 2 from Comparative Study on the Efficacy and Exposure of Molecular Target Agents in Non–small Cell Lung Cancer PDX Models with Driver Genetic Alterations
50. Supplementary Figures from High-Throughput Functional Evaluation of MAP2K1 Variants in Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.